Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FindexTSE:3649 +0.61%95 Return-on-Tangible-Equity is 0.00% as of Dec. 2025. GuruFocus rates TSE:3649 with a GF Score™ of 95/100 and a GF Value™ of 円933.27 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 575 Healthcare Providers & Services companies, Findex ranks better than 54.78% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Findex's annualized net income for the quarter that ended in Dec. 2025 was 円0 Mil. Findex's average shareholder tangible equity for the quarter that ended in Dec. 2025 was 円5,062 Mil. Therefore, Findex's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 0.00%.
The historical rank and industry rank for Findex's Return-on-Tangible-Equity or its related term are showing as below:
TSE:3649'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 12.67 Med: 21.46 Max: 25.41
Current: 12.67
During the past 13 years, Findex's highest Return-on-Tangible-Equity was 25.41%. The lowest was 12.67%. And the median was 21.46%.
TSE:3649's Return-on-Tangible-Equity is ranked better than 54.78% of 575
companies
in the Healthcare Providers & Services industry
Industry Median: 10.45
vs TSE:3649: 12.67
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Findex Return-on-Tangible-Equity Related Terms
Findex Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Findex's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3649 vs VEEV, BTSG, HQY: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, Findex's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Findex Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Findex's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Findex's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
Findex (TSE:3649) has a Return-on-Tangible-Equity of 0.00% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Findex and its competitors. Over the past decade, Findex's Return-on-Tangible-Equity has ranged from 12.67 to 25.41. According to the industry distribution chart, Findex ranks #260 out of 575 companies in the Healthcare Providers & Services industry, placing it in the top 45.2%.
Is Findex's Return-on-Tangible-Equity too high?
Findex's current Return-on-Tangible-Equity is 0.00%. Over the past 10 years, this metric has ranged from a low of 12.67 to a high of 25.41. Based on the distribution chart, Findex ranks #260 out of 575 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Findex has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Findex's Return-on-Tangible-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Findex ranks #260 out of 575 companies for Return-on-Tangible-Equity. This puts Findex in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.45. Historically, Findex's own Return-on-Tangible-Equity has ranged from 12.67 to 25.41 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.45, based on 575 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Findex and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Findex's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Findex stock overvalued right now?
Based on GuruFocus' analysis, Findex (TSE:3649) is currently considered Modestly Undervalued. The stock's GF Value™ is 円933.27, compared to a current price of 円826.00 — trading 11.5% below its estimated fair value. The current Return-on-Tangible-Equity is 0.00%. Findex's overall GF Score™ is 95/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Findex (TSE:3649), the current Return-on-Tangible-Equity is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Findex (TSE:3649) Overvalued in 2026?
Based on GuruFocus' analysis, Findex stock appears to be undervalued.
The current stock price of 円826.00 is trading 11.5% below its estimated GF Value™ of 円933.27.
GuruFocus considers Findex to be Modestly Undervalued.
Key valuation signals for TSE:3649:
Return-on-Tangible-Equity: 0.00%
GF Value™: 円933.27 vs. price of 円826.00 (11.5% below fair value)
No single metric tells the full story. See the TSE:3649 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3649 has been successfully added to your 
